Arrowhead Pharmaceuticals Inc. (ARWR) Posts FY21 Loss of $1.36/Share
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported FY 2021 EPS of ($1.36), versus ($0.84) last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.